Skip to main content
Clinical Trials/ITMCTR2022000097
ITMCTR2022000097
Recruiting
未知

Study on the effective prescriptions for the treatment of liver injury and their anti-inflammatory and hepatoprotective mechanisms by famous old Chinese medicine practitioners

Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic liver injury
Sponsor
Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • ? Diseases related to abnormal liver function that have been differentiated and treated by famous Chinese medicine practitioners, mainly including: viral hepatitis, alcoholic liver disease, non\-alcoholic steatohepatitis, autoimmune hepatitis, liver cirrhosis, drug\-induced liver injury, etc.;
  • ? Complete medical record information, including: general information of patients, symptoms and signs, information on four diagnoses, diagnosis of traditional Chinese and Western medicine, syndromes, principles and methods of treatment, name and composition of prescriptions, auxiliary examinations, etc.;
  • ? Mainly using traditional Chinese medicine treatment, including pure traditional Chinese medicine treatment, or using traditional Chinese medicine alone for more than 80% of the time in the treatment cycle;
  • ? There is information on follow\-up visits, at least 2 visits, and liver function assessment before and after treatment, with written records or auxiliary examinations that clearly prove the curative effect.

Exclusion Criteria

  • ? The patient's medical record information and data are incomplete, which affects the assessment and data analysis;
  • ? Combined with acute and chronic serious diseases of important organs (such as heart, brain, lung, liver, kidney).

Outcomes

Primary Outcomes

Not specified

Similar Trials